Alternatives to Cradle

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

AI-powered materials science and discovery platform to accelerate scientific breakthroughs.

AI-guided drug discovery platform for tissue-targeted medicines.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

Biotech company focused on designing and developing novel biological solutions.

Leveraging the adaptive immune system to diagnose and treat disease.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Vexxel is developing a novel platform for cell-free protein synthesis and engineering.

AI-powered drug discovery and development platform for biologics.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Advance every cancer decision.

Seevix Material Sciences develops and produces SVX, a proprietary spider silk protein, for various industrial and medical applications.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

Biotechnology company

AI-powered platform for antibody discovery and development to create new medicines.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Biotechnology company specializing in antibody discovery and protein engineering for therapeutic applications.

Developing novel protein-based solutions for industrial and therapeutic applications.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

BigHat Biosciences combines machine learning and synthetic biology to design and engineer novel antibodies and other therapeutic proteins.

Valthos is an applied biological intelligence company. We develop and deploy software and AI methods to outsmart biological evolution and ensure that these tools are deployed to safeguard humanity.

AI-driven biotech company engineering novel proteins for therapeutics and sustainability.

AI-powered breast cancer detection and risk assessment solutions.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Synthetic biology platform for environmental sustainability solutions.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Advancing next-generation mRNA medicines.

AI-driven predictive modeling company focused on biology and life sciences.

AI-powered biotech platform using protein design to discover novel therapeutic molecules for hard-to-treat targets.

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Narya Bio is developing novel therapeutic antibodies for challenging diseases.

A biotechnology company focused on oncology drug discovery.

Building General Biological Intelligence

Synthetic biology startup optimizing gene expression for food and biotech applications.

AI-enabled technology for cell biology research and biopharma development.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.